• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

T2加权图像的纹理分析作为慢性肾脏病微观结构状态的可靠生物标志物

Texture Analysis of T2-Weighted Images as Reliable Biomarker of Chronic Kidney Disease Microstructural State.

作者信息

Majos Marcin, Klepaczko Artur, Szychowska Katarzyna, Stefanczyk Ludomir, Kurnatowska Ilona

机构信息

Department of Normal and Clinical Anatomy, Medical University of Lodz, 90-419 Lodz, Poland.

I Department of Radiology and Diagnostic Imaging, Medical University of Lodz, 90-419 Lodz, Poland.

出版信息

Biomedicines. 2025 Jun 4;13(6):1381. doi: 10.3390/biomedicines13061381.

DOI:10.3390/biomedicines13061381
PMID:40564100
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12189524/
Abstract

: The diagnostics of chronic kidney disease (CKD) consist of three basic groups of examinations: laboratory tests, radiological imaging and histopathological examinations. However, in the most severe clinical cases, where a fast, undisputed decision is required, histopathological tests are the only suitable option. Unfortunately, such tests require an invasive kidney biopsy, which is not possible in many patients. The aim of this study is to create an algorithm that can categorize CKD patients into active and non-active phases on the basis of MRI texture analysis and compare the results with histopathological examinations. : MRI examinations were performed on healthy volunteers (group 1, N = 14) and CKD patients who also received kidney biopsy. The histopathological examination was used to divide the patients into active phase CKD (group 2, N = 58) and non-active phase CKD (group 3, N = 22). The T2-weighted MRI images were analyzed using a Support Vector Machine (SVM) model created with qMazDa software, which was trained to classify images into the appropriate group of CKD activity. : The following evaluation metrics were calculated for the final SVM models corresponding to confusion matrices: for texture analysis-balanced accuracy 81.6%, sensitivity 68.2-92.0%, specificity 82.5-97.5% and precision 62.5-95.8%; for texture and shape analysis-balanced accuracy 87.3%, sensitivity 77.3-100.0%, specificity 87.5-100.0% and precision 65.4-100.0%. : Texture analysis of T2-weighted images associated with kidney shape features seems to be reliable method of assessing the state of ongoing CKD.

摘要

慢性肾脏病(CKD)的诊断包括三组基本检查:实验室检查、放射影像学检查和组织病理学检查。然而,在最严重的临床病例中,需要快速、无争议的诊断,组织病理学检查是唯一合适的选择。不幸的是,此类检查需要进行侵入性肾活检,而许多患者无法进行。本研究的目的是创建一种算法,该算法可以基于MRI纹理分析将CKD患者分为活动期和非活动期,并将结果与组织病理学检查进行比较。

对健康志愿者(第1组,N = 14)和也接受了肾活检的CKD患者进行了MRI检查。组织病理学检查用于将患者分为CKD活动期(第2组,N = 58)和非CKD活动期(第3组,N = 22)。使用qMazDa软件创建的支持向量机(SVM)模型分析T2加权MRI图像,该模型经过训练可将图像分类到适当的CKD活动组。

针对与混淆矩阵对应的最终SVM模型计算了以下评估指标:纹理分析——平衡准确率81.6% , 灵敏度68.2 - 92.0% , 特异性82.5 - 97.5% , 精确率62.5 - 95.8%;纹理和形状分析——平衡准确率87.3% , 灵敏度77.3 - 100.0% , 特异性87.5 - 100.0% , 精确率65.4 - 100.0%。

与肾脏形状特征相关的T2加权图像的纹理分析似乎是评估正在进行的CKD状态的可靠方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1d1/12189524/7a13b26d5b92/biomedicines-13-01381-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1d1/12189524/e13a831bd56a/biomedicines-13-01381-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1d1/12189524/fe675a2ea87c/biomedicines-13-01381-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1d1/12189524/396b6b0bf35e/biomedicines-13-01381-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1d1/12189524/7a13b26d5b92/biomedicines-13-01381-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1d1/12189524/e13a831bd56a/biomedicines-13-01381-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1d1/12189524/fe675a2ea87c/biomedicines-13-01381-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1d1/12189524/396b6b0bf35e/biomedicines-13-01381-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1d1/12189524/7a13b26d5b92/biomedicines-13-01381-g004.jpg

相似文献

1
Texture Analysis of T2-Weighted Images as Reliable Biomarker of Chronic Kidney Disease Microstructural State.T2加权图像的纹理分析作为慢性肾脏病微观结构状态的可靠生物标志物
Biomedicines. 2025 Jun 4;13(6):1381. doi: 10.3390/biomedicines13061381.
2
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
3
Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.首次就诊时磁共振灌注成像用于鉴别低级别与高级别胶质瘤
Cochrane Database Syst Rev. 2018 Jan 22;1(1):CD011551. doi: 10.1002/14651858.CD011551.pub2.
4
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂用于患有早期(1至3期)非糖尿病慢性肾病的成人。
Cochrane Database Syst Rev. 2011 Oct 5(10):CD007751. doi: 10.1002/14651858.CD007751.pub2.
5
Intraoperative frozen section analysis for the diagnosis of early stage ovarian cancer in suspicious pelvic masses.术中冰冻切片分析用于诊断可疑盆腔肿块中的早期卵巢癌。
Cochrane Database Syst Rev. 2016 Mar 1;3(3):CD010360. doi: 10.1002/14651858.CD010360.pub2.
6
The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.戈谢病酶替代疗法的临床疗效和成本效益:一项系统评价。
Health Technol Assess. 2006 Jul;10(24):iii-iv, ix-136. doi: 10.3310/hta10240.
7
The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.卡莫司汀植入剂与替莫唑胺治疗新诊断的高级别胶质瘤的有效性和成本效益:一项系统评价与经济学评估
Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. doi: 10.3310/hta11450.
8
Imaging modalities for the non-invasive diagnosis of endometriosis.子宫内膜异位症非侵入性诊断的成像方式
Cochrane Database Syst Rev. 2016 Feb 26;2(2):CD009591. doi: 10.1002/14651858.CD009591.pub2.
9
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
10
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.

本文引用的文献

1
The Pathophysiology and Vascular Complications of Diabetes in Chronic Kidney Disease: A Comprehensive Review.慢性肾脏病中糖尿病的病理生理学与血管并发症:综述
Cureus. 2024 Dec 28;16(12):e76498. doi: 10.7759/cureus.76498. eCollection 2024 Dec.
2
Functional magnetic resonance imaging for staging chronic kidney disease: a systematic review and meta-analysis.功能磁共振成像在慢性肾脏病分期中的应用:系统评价和荟萃分析。
Int Urol Nephrol. 2024 Sep;56(9):2971-2981. doi: 10.1007/s11255-024-04055-z. Epub 2024 Apr 17.
3
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.
KDIGO 2024慢性肾脏病评估与管理临床实践指南
Kidney Int. 2024 Apr;105(4S):S117-S314. doi: 10.1016/j.kint.2023.10.018.
4
Application of MR Imaging Characteristics in the Differentiation of Renal Changes Between Patients with Stage III Type 2 Diabetic Kidney Disease and Healthy People.磁共振成像特征在Ⅲ期2型糖尿病肾病患者与健康人肾脏变化鉴别中的应用
Diabetes Metab Syndr Obes. 2023 Jul 24;16:2177-2186. doi: 10.2147/DMSO.S413688. eCollection 2023.
5
Value of multiparametric magnetic resonance imaging for evaluating chronic kidney disease and renal fibrosis.多参数磁共振成像在评估慢性肾脏病和肾纤维化中的价值
Eur Radiol. 2023 Aug;33(8):5211-5221. doi: 10.1007/s00330-023-09674-1. Epub 2023 May 6.
6
Effectiveness of functional magnetic resonance imaging for early identification of chronic kidney disease: A systematic review and network meta-analysis.功能磁共振成像对慢性肾脏病早期识别的有效性:系统评价和网络荟萃分析。
Eur J Radiol. 2023 Mar;160:110694. doi: 10.1016/j.ejrad.2023.110694. Epub 2023 Jan 11.
7
Diabetes Management in Chronic Kidney Disease: Synopsis of the KDIGO 2022 Clinical Practice Guideline Update.慢性肾脏病中的糖尿病管理:KDIGO 2022临床实践指南更新概要
Ann Intern Med. 2023 Mar;176(3):381-387. doi: 10.7326/M22-2904. Epub 2023 Jan 10.
8
The utility of texture analysis of kidney MRI for evaluating renal dysfunction with multiclass classification model.基于多分类模型的肾脏 MRI 纹理分析在肾功能障碍评估中的应用。
Sci Rep. 2022 Aug 30;12(1):14776. doi: 10.1038/s41598-022-19009-7.
9
Diffusion-Weighted Imaging and Mapping of T1 and T2 Relaxation Time for Evaluation of Chronic Renal Allograft Rejection in a Translational Mouse Model.在一个转化小鼠模型中,利用扩散加权成像以及T1和T2弛豫时间映射来评估慢性同种异体肾移植排斥反应
J Clin Med. 2021 Sep 23;10(19):4318. doi: 10.3390/jcm10194318.
10
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases.KDIGO 2021肾小球疾病管理临床实践指南。
Kidney Int. 2021 Oct;100(4S):S1-S276. doi: 10.1016/j.kint.2021.05.021.